Clinical Trial Update: Effects of RG1068 (Secretin) on Information Processing in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating RG1068 (Secretin) for information processing in schizophrenia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RG1068 (Secretin) (secretin)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED